Adjuvant docetaxel, doxorubicin, and cyclophosphamide in node-positive breast cancer: 10-year follow-up of the phase 3 randomised BCIRG 001 trial

1. Mackey, J.R.
2. Martin, M.
3. Pienkowski, T.
4. Rolski, J.
5. Guastalla, J.-P.
6. Sami, A.
7. Glaspy, J.
8. Juhos, E.
9. Wardley, A.
10. Fornander, T.
11. Hainsworth, J.
12. Coleman, R.
13. Modiano, M.R.
14. Vinholes, J.
15. Pinter, T.
16. Rodríguez-Lescure, Á.
17. Colwell, B.
18. Whitlock, P.
19. Provencher, L.
20. Laing, K.
21. Walde, D.
22. Price, C.
23. Hugh, J.C.
24. Childs, B.H.
25. Bassi, K.
26. Lindsay, M.-A.
27. Wilson, V.
28. Rupin, M.
29. Houé, V.
30. Vogel, C.
31. Show all authors +